Netherlands-based FeyeCon Carbon Dioxide Technologies has signed a technology acquisition agreement with Malaysian Biotechnology Corporation (BiotechCorp) to roll out carbon dioxide technology in Asia.

FeyeCon was quoted by Bernama news agency as saying in a statement that the technology involved focused on natural product production and development.

"The world market for natural products is currently valued at 80 billion USD, with Malaysia moving to become a key player in the market,” BiotechCorp chief executive officer Iskandar Mizal Mahmood was quoted as saying.

He added that “The natural product industry is also set to become another important source of revenue generation for the country"./.